908 DEVICES INC. Contract Liability (Deferred Revenue)
908 DEVICES INC. (MASS) had Contract Liability (Deferred Revenue) of $10.71 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2026-08-11
- 2026-06-30: Contract with Customer, Liability, Current $10.71M.
- 2026-03-31: Contract with Customer, Liability, Current $9.47M.
- 2025-12-31: Contract with Customer, Liability, Current $8.93M.
- 2025-09-30: Contract with Customer, Liability, Current $9.11M.
| Period end | Contract with Customer, Liability, Current | Contract with Customer, Liability, Current as first filed |
|---|---|---|
| 2026-06-30 | $10.71M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $9.47M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $8.93M 10-Q · filed 2026-08-11 | |
| 2025-09-30 | $9.11M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $8.83M 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $9.70M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $10.42M 10-K · filed 2026-03-09 | $12.13M 10-K · filed 2025-03-07 |
| 2024-09-30 | $13.86M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $11.95M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $10.48M 10-Q · filed 2024-05-03 | |
| 2023-12-31 | $10.63M 10-K · filed 2025-03-07 | |
| 2023-09-30 | $10.52M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $10.81M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $8.00M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $7.51M 10-K · filed 2024-03-08 | |
| 2022-09-30 | $7.42M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $6.84M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $5.78M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $5.16M 10-K · filed 2023-03-15 | |
| 2021-09-30 | $4.84M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $3.96M 10-Q · filed 2021-08-04 | |
| 2021-03-31 | $3.32M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $3.10M 10-K · filed 2022-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |